NEWS ABOUT US EXPERIENCE STRATEGY TEAM PORTFOLIO CONTACT US

c
 

NEWS

2014 | 2013 | 2012 | 2010 | 2009

 

 

 


Aveo Pharmaceuticals
December 22, 2011 - AVEO Announces Patient Enrollment in Phase 2 Clinical Trial of Tivozanib in Combination with mFOLFOX6 in Patients with Advanced Colorectal Cancer
Press Release | Company News


Amicus Therapeutics
December 19, 2011 - Amicus Therapeutics Completes Enrollment of 67 Patients in Phase 3 Study of Migalastat HCl for Fabry Disease
Press Release | Company News


Kythera Biopharmaceuticals
December 14, 2011 - Kythera Biopharmaceuticals Receives Notice of Allowance for Additional U.S. Patent on ATX-101 (Formulations Of Deoxycholic Acid and Salts)
Press Release | Company News


Emergent BioSolutions
December 1, 2011 - Emergent BioSolutions Receives Orphan Drug Designation for Its TRU-016 Protein Therapeutic for the Treatment of Chronic Lymphocytic Leukemia
Press Release | Company News


Amicus Therapeutics
December 1, 2011 - Amicus Therapeutics Announces First Patient in Phase 2 Study for Pompe Disease(TM) for Fabry Disease
Press Release | Company News


Portola Pharmaceuticals
November 21, 2011 - Portola Pharmaceuticals Announces Completion of $89 Million Financing
Press Release | Company News


DFine
November 8, 2011 - DFine, Inc. Announces Close of $25 Million Financing
Press Release | Company News


Hansen Medical
November 7, 2011 - Hansen Medical Announces Agreement for Private Placement of Common Stock
Press Release | Company News


DFine
November 1, 2011 - DFine Awarded U.S. Department of Veterans Affairs Five-Year Contract for StabiliT Vertebral Augmentation System
Press Release | Company News


Baxano, Inc.
October 31, 2011 - Baxano Rapidly Expands Sales Force to Support Robust Demand for the iO-Flex(R) System
Press Release | Company News


Portola Pharmaceuticals
October 27, 2011 - Biogen Idec and Portola Pharmaceuticals Announce Global Collaboration for Oral Syk Inhibitor Program Targeting Autoimmune and Inflammatory Diseases
Press Release | Company News


NinePoint Medical
October 24, 2011 - NinePoint Medical Announces New Data Presented on Innovative Optical Frequency Domain Imaging Technology at 19th UEGW Meeting
Press Release | Company News


Amicus Therapeutics
October 19, 2011 - Amicus Therapeutics Announces Close of Patient Recruitment in First Phase 3 Study of Amigal(TM) for Fabry Disease
Press Release | Company News


Hansen Medical
October 19, 2011 - Hansen Medical Announces Initiation of Clinical Trial Evaluating Sensei(R) X Robotic System for Ventricular Tachycardia
Press Release | Company News


Topica Pharmaceuticals
October 18, 2011 - Topica Announces Completion of $27 Million Series B Financing
Press Release | Company News


Complete Genomics
October 12, 2011 - Complete Genomics Launches Comprehensive Cancer Sequencing Service at ICHG/ASHG 2011
Press Release | Company News


Azelon Pharmaceuticals
October 11, 2011 - Azelon Pharmaceuticals Secures $4.5 million in Series A Financing to Support Phase 2 Study of Nasal Spray Teriparatide (PTH1-34) for the Treatment of Osteoporosis
Press Release | Company News


Kythera Biopharmaceuticals
September 19, 2011 - Kythera Biopharmaceuticals Announces $37.4M Financing
Press Release | Company News


Amicus Therapeutics
September 12, 2011 - Amicus Therapeutics and GlaxoSmithKline Commence Second Phase 3 Study of Amigal(TM) for Fabry Disease
Press Release | Company News


Baxano, Inc.
September 12, 2011 - Baxano Enrolls First Patient in Groundbreaking STRiDE Trial
Press Release | Company News


Panmira Pharmaceuticals
September 8, 2011 - Panmira and FLAP LLCs Spun Out of Amira Pharmaceuticals
Press Release | News Article


Amira Pharmaceuticals
September 7, 2011 - Amira Pharma on How it Beat the Odds, and Sold an Early Stage Drug to Bristol-Myers for $325M
News Article


Complete Genomics
August 25, 2011 - Complete Genomics Appoints Chief Commercial Officer and Chief Medical Officer
Press Release | Company News


Complete Genomics
August 24, 2011 - Complete Genomics to Sequence More Than 1,000 Additional Genomes for National Cancer Institute’s Pediatric Cancer Study
Press Release | Company News


Emergent BioSolutions
August 17, 2011 - Emergent Announces Initiation of a Phase 1b/2 Study of TRU-016 in Combination with Rituximab and Bendamustine in Subjects with Relapsed - Indolent Lymphoma
Press Release | Company News


Hansen Medical
July 25, 2011 - Hansen Medical Receives CE Mark for Its Magellan(TM) Robotic System for Peripheral Vascular Interventions
Press Release | Company News


Amira Pharmaceuticals
July 21, 2011 - Bristol-Myers Squibb to Acquire Amira Pharmaceuticals for up to $475 million
Press Release | News Article


Amicus Therapeutics
June 29, 2011 - Amicus Therapeutics Announces John F. Crowley to Return as Chairman and Chief Executive Officer
Press Release | Company News


DFine
June 28, 2011 - DFine Announces First Patient Treated with Star™ System in a Clinical Trial to Evaluate Targeted Radiofrequency Ablation Therapy for Spinal Tumors
Press Release | Company News


Topica Pharmaceuticals
June 20, 2011 - Topica Announces Positive Results from Phase 1/2a Trial of Luliconazole for Treatment of Onychomycosis
Press Release | Company News


Gloucester Pharmaceuticals (CELG)
June 16, 2011 - FDA Grants Accelerated Approval of ISTODAX(R) As Treatment for Patients with Peripheral T-Cell Lymphoma Who Have Received at Least One Prior Therapy
Press Release | News Article


Insmed
June 10, 2011 - Insmed's ARIKACE® Demonstrates Sustained Benefit Through Six Cycles of Treatment for Cystic Fibrosis Patients With Pseudomonas Lung Infections
Press Release | Company News


Aveo Pharmaceuticals
May 31, 2011 - AVEO's Ficlatuzumab in Combination with Gefinitib Well Tolerated in Patients with Non-Small Cell Lung Cancer
Press Release | Company News


Complete Genomics
May 26, 2011 - Complete Genomics Announces Pricing of Public Offering
Press Release | Company News


Complete Genomics
May 18, 2011 - Erasmus University Medical Center Partners With Complete Genomics to Begin Developing Its Genomic Medicine Pipeline
Press Release | Company News


Hansen Medical
May 5, 2011 - Hansen Medical Announces Shipment of 100th Sensei(R) Robotic Catheter System
Press Release | Company News


Amira Pharmaceuticals

May 2, 2011 - Amira Pharmaceuticals Announces Completion of Phase 1 Clinical Study for AM152, A Novel LPA1 Receptor Antagonist
Press Release | Company News


Novavax
April 19, 2011 - Novavax Announces Change in Leadership
Press Release | Company News


Amira Pharmaceuticals

April 19, 2011 - Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis
Press Release | Company News


Aveo Pharmaceuticals
April 12, 2011 - AVEO Pharmaceuticals Appoints Henri A. Termeer to its Board of Directors
Press Release | Company News


Hansen Medical
April 11, 2011 - Hansen Medical Submits 510(k) Application With U.S. FDA for Vascular Robotic System and Catheter
Press Release | Company News


Baxano, Inc.
April 8, 2011 - Baxano, Inc. iO-Flex™ System Awarded Medical Design Excellence Award
Press Release | Company News


Novavax
April 5, 2011 - Novavax’s VLP Influenza Vaccine Named One of Top 100 Drugs in Development Today
Press Release | Company News


Hansen Medical
March 31, 2011 - Hansen Medical Announces First Ever Public Exhibit of Its Vascular Robotic System at Key European Meeting of Vascular Surgeons
Press Release | Company News


Insmed
March 21, 2011 - Insmed Announces FDA Clearance of IND for Pivotal Phase 3 Trial of ARIKACE™ in Nontuberculous Mycobacteria Indication
Press Release | Company News


Infinity Pharmaceuticals
March 3, 2011 - Infinity Initiates Phase 2 Trial of IPI-926 in Patients With Chondrosarcoma
Press Release | Company News


Novavax
March 1, 2011 - NOVAVAX Awarded HHS-BARDA Contract Valued at up to $179 Million to Develop Pandemic and Seasonal Influenza Vaccines for U.S. Government Using Recombinant VLP Technology
Press Release | Company News


Infinity Pharmaceuticals
February 22, 2011 - Infinity Initiates Phase 2 Portion of Trial of IPI-926 in Pancreatic Cancer
Press Release | Company News


Kythera Biopharmaceuticals
February 22, 2011 - Kythera Biopharmaceuticals Presents Positive Data from Phase IIB Study with ATX-101 Demonstrating Reduction of Submental Fat
Press Release | Company News


Complete Genomics
February 21, 2011 - Complete Genomics Selected by MIT’s Technology Review for Top 50 Innovative Companies List
Press Release | Company News


Novavax
February 18, 2011 - NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting
Press Release | Company News


Aveo Pharmaceuticals
February 16, 2011 - Astellas and AVEO Pharmaceuticals Enter into Worldwide Agreement to Develop and Commercialize Tivozanib Outside of Asia
Press Release | Company News


Amicus Therapeutics
February 16, 2011 - Amicus Therapeutics Provides Positive Data Update from Phase 2 Long-Term Extension Study of Amigal™ for Fabry Disease
Press Release | Company News


Baxano, Inc.
February 11, 2011 - Baxano, Inc. Awarded Top 10 of 2010 Medical Technology
Press Release | Company News


Amicus Therapeutics
February 9, 2011 - Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal™ Co-administered with Enzyme Replacement Therapy
Press Release | Company News


Complete Genomics
February 3, 2011 - Complete Genomics is Publicly Releasing a Large Sequencing Dataset—60 Complete, High-coverage Human Genomes—for Study by the Global Research Community
Press Release | Company News


Hansen Medical
February 3, 2011 - Hansen Medical and Philips Enter Agreements for the Development of Non-Robotic Applications of Fiber Optic Shape Sensing and Localization Technology
Press Release | Company News


Portola Pharmaceuticals
January 28, 2011 - Portola Drug Targets Market of $2 Billion
Press Release | Media Coverage


Complete Genomics
January 11, 2011 - The Institute for Systems Biology Places a Third Order for Sequencing Services With Complete Genomics, Includes 615 Genomes
Press Release | Company News


Topica Pharmaceuticals
January 11, 2011 - Topica Announces Enrollment of First Patient in Phase 1/2a Trial of Luliconazole for Treating Onychomycosis
Press Release | Company News


Kythera Biopharmaceuticals
January 10, 2011 - Kythera and Intendis Announce Initiation of European Phase III Clinical Development Program to Evaluate ATX-101 for Reduction of Submental Fat
Press Release | Company News


Novavax
January 3, 2011 - NOVAVAX Launches Phase I Clinical Trial to Evaluate its Novel Vaccine Against Respiratory Syncytial Virus (RSV)
Press Release | Company News

 

News Archives